# Systematic Analysis of the Whole-Body Tissue Distribution and Fatty Acid Compositions of Membrane Lipids in CD1 and NMRI Mice and Wistar Rats

Authors: Lina Xu; Maximilian V. Schmitt; Huabin Ruan; Yupei Jiao; Xueying Wang; Yusong Wang; Tao Yang; Philip Lienau; Andreas Reichel; Xiaohui Liu
Journal: International Journal of Analytical Chemistry
 (2020)

---

## Abstract

Understanding the tissue distribution of phospholipids and glycerolipids in animal models enables promoting the pharmacokinetic study of drugs and related PK predictions. The measurement of lipid compositions in animal models, usually mice and rats, without a standardized approach hindered the accuracy of PBPK investigation. In this work, high resolution mass spectrometry was applied to profile the tissue distribution of phospholipids and glycerolipids in 12 organs/tissues of mice and rats. Using this method, not only the amounts of phospholipids and glycerolipids in each organ/tissue but also the fatty acid compositions were acquired. In order to explore the interspecies specificity of lipid distribution in different organs/tissues, three animal species including CD1 mice, NMRI mice, and Wister rats were used in this systematic study. Globally, more organ specificity was observed. It was found that the brain is the organ containing the most abundant phosphatidylserine lipids (PSs) in all three animal models, leading to brain tissues having the most concentrated acidic phospholipids. Diverse fatty acid compositions in each lipid class were clearly revealed. Certain tissues/organs also had a specific selection of unique fatty acid compositions, for example, unreferenced FA(18 : 2) in the brain. It turned out that the access of free fatty acids affects the incorporation of acyl chain in phospholipids and glycerolipids. In the analysis, ether lipids were also profiled with the observation of dominant ePEs in brain tissues. However, little interspecies difference was found for fatty acid constituents and tissues distribution of phospholipids and glycerolipids.


---

## Body

## 1. Introduction

Phospholipids and glycerolipids are major lipid constituents of cell membranes. They are also involved in many cellular processes in health and disease. Various diseases have been reported to correlate with lipid metabolism [1–5] and several studies revealed changes in lipid regulation in animal and human tissues for different diseases [6–10]. The primary function of the highly abundant phospholipids and glycerolipids though is to support the structure of the cellular membrane. The lipid composition of cell membranes and tissues plays an important role in determining the pharmacokinetics (PK) of drugs, in particular their tissue partitioning which to a large extent is controlled by the lipid components in the body tissues [11–15]. There is great interest in accurate a priori predictions of drug-tissue partition coefficients based on the tissue composition in human or preclinical animal species15. Physiologically based PK (PBPK) models, therefore, need to account for species differences in lipid constituents that determine drug-tissue distribution. Although previous reports suggest the existence of species differences in the lipid tissue composition [16], lipid constituents in various animal strains have mostly been investigated individually in different studies using different protocols [17–19]. However, measurements using different methods and techniques may introduce a significant amount of bias into interspecies comparison and their corresponding PK predictions and different tissue dissection and storage conditions may also lead to inaccuracies of lipid investigation. Therefore, there is a need for a more systematic analysis of animal species and strain differences of tissue lipid constituents using the same analytical approach.Mass spectrometry (MS) is a powerful tool for comprehensive lipidomic analysis including accurate molecular identification and quantitation. Multiple analytical platforms with MS have been developed. Shotgun lipidomics based on direct infusion was first introduced for complex lipid analysis using distinctive neutral loss scans [20–24]. Coupling of liquid chromatography (LC) powers and simplifies large-scale analysis of MS for complicated biological systems. Targeted lipidomics using LC-MS/MS is an alternative method for lipid analysis [25–27]. Selected reaction monitoring (SRM) is applied for data acquisition, supplying high sensitivity and wide linearity. Recently, high resolution MS has become more popular for comprehensive lipid analysis [28–31]. Data-dependent acquisition (DDA) enables confident lipid identification based on MS/MS assignment. The presence of abundant MS/MS spectral libraries, for example, LipidBlast, LIPID MAPS, or LipidSearch, allows the comprehensive analysis of lipidome in cells and animals [32–35].In this work, phospholipids including phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylglycerol (PG), cardiolipin (CL), and lysophospholipids (LPLs) and glycerolipids including diglyceride (DG) and triglyceride (TG) in 12 organs/tissues of Wistar rats and CD1 and NMRI mice were profiled using Orbitrap based high resolution mass spectrometry. Lipid identification using DDA and MS-based quantitation was applied. Specific strategies for false positive elimination were used to improve the confidence of lipid analysis. Using this method, the fatty acid constituents of phospholipids and glycerolipids could be resolved. This allows the comparison of lipid composition in the animal organs of species and strains. Ether lipids including plasmanyl- and plasmenyl-phospholipids were also analyzed to explore the animal organ or species dependency of acyl chain components.


## 2. Materials and Methods

### 2.1. Sample Collection of Rats and Mice

All animal experiments were conducted in accordance with the German animal welfare laws and approved by local authorities. Animals were kept on a diet based on rodent’s ssniffTM pellets “Ratte/Maus-Haltung” (ssniff-Spezialdiäten GmbH, Soest, Germany) and water ad libitum. Tissue samples of brain, heart, liver, kidney, spleen, stomach, lung, muscle, small intestine, large intestine, skin, and fat were collected from individual male Wistar rats (HsdRCCHan:Wistar, Envigo, NL; weight range: 256–302 g), female NMRI mice (Crl:NMRI BR, Charles River, Germany; weight range: 28–30 g), and female CD1 mice (Crl:CD1(Icr), Charles River, Germany; weight range: 27–31 g) with nine replicates, respectively. Solid tissues were excised, briefly washed with isotonic NaCl solution to wash off blood residues. The stomach and the intestines were additionally cleared of their content with NaCl washing solution. The whole organs were collected, except for skin (4 cm2, belly), fat (5 g, abdominal fat), and muscles (5 g, belly/leg). All samples were immediately shock frozen in liquid nitrogen after preparation.


### 2.2. Lipid Extraction from 12 Organs/Tissues of Wistar Rat and CD1 and NMRI Mice

Lipids were extracted as previously described [36]. Briefly, 50 mg wet tissue samples were homogenized in 500 μL of chloroform/methanol (v : v = 2 : 1) with an internal standard solution. Aqueous was subsequently added. Solutions were vortexed for 1-2 min and prepared for extraction with three replicates. Then, samples were centrifuged for 5 mins at 1000 rpm for phase separation. The lower organic layer was transferred using a glass syringe and dried under nitrogen. Lipid samples were stored in −80°C dry pellets. During lipid extraction, 5 mL glass tubes were used in order to avoid contamination.


### 2.3. Lipidomic Analysis Using LC-MS/MS

Reverse phase chromatography was selected for LC separation using CORTECS C18 Column (2.1 × 100 mm, Waters). Mobile phase A was made by mixing 400 mL of HPLC-grade water containing 0.77 g of ammonium acetate with 600 mL of HPLC-grade acetonitrile (pH ∼7). Mobile phase B contained 10% ACN and 90% IPA (v/v). Data was acquired using Q Exactive Orbitrap mass spectrometer (Thermo, CA) coupled with UHPLC system Ultimate 3000 (Thermo, CA). Data-dependent acquisition (DDA) was performed with 70,000 MS resolution and 17,500 MS/MS resolution. MS/MS spectra were acquired from the top 10 most intense precursors. Stepped NCE (normalized collision energy) of 15, 25, 35 was applied for fragmentation.


### 2.4. Identification of Phospholipids and Glycerolipids

Lipids were identified using LipidSearch software v4.1.16 (Thermo, CA). LipidSearch v4.1.16 has 1,500,000 fragment ions of 71 subspecies in the database. It allows lipid identification based on MS/MS match [23] and ID-based quantitation was performed. Mass tolerance of 8 ppm and 15 ppm was set for precursor and fragment, respectively. The displayed m-score threshold was selected as 5 and grades A, B, C, D were all used for ID quality filter. Adducts of +H, +NH4 were used for positive mode search and −H, +CH3COO− were chosen for negative mode. Thresholds of m-core and chromatographic peak shapes were applied to eliminate false positives.


### 2.5. Quantitation of Phospholipids and Glycerolipids

Stock solutions of 10 mg/mL PC (18 : 0/18 : 0), PE (18 : 0/18 : 0), PI (16 : 0/16 : 0), PS (16 : 0/16 : 0), PG (18 : 0/18 : 0), CL (18 : 1/18 : 1/18 : 1/18 : 1), DG (16 : 0/18 : 0), and TG (16 : 0/16 : 0/18 : 0) were prepared. Then, a series of calibration solutions, with concentrations of from 1 ng/mL up to 200µg/mL, were diluted using CH2Cl2 : MeOH = 2 : 1. Internal standard solution containing PC (14 : 0/14 : 0), PE (14 : 0/14 : 0), PI (8 : 0/8 : 0) PS (14 : 0/14 : 0), PG (14 : 0/14 : 0), CL (14 : 0/14 : 0/14 : 0/14 : 0), DG (14 : 0/14 : 0), and TG (16 : 0/16 : 0/18 : 0)-D7 were made. Equal volumes of calibration solution and internal standard solution were mixed. Injection volume of 1 µL was used for the analysis.


### 2.6. Analysis of Glycerophospholipids and Glycerolipids in Mouse Brain Tissues

C57BL/6 mice at the age of 12 and 96 weeks were dissected and lipids in frozen brain tissues were extracted according to the protocols in section2.2. Five replicates were used in the analysis. Glycerophospholipids were analyzed in negative ion mode using UHPLC-Q Exactive Orbitrap MS whereas DG and TG lipid molecules were analyzed in positive ion mode. The acyl chain component analysis was performed for each lipid class based on the abundance of lipid molecules. The abundance of lipid molecule was considered to contribute equally to each fatty acid component. Therefore, the percentage of specific acyl chain components in a certain lipid class was calculated using the total abundance of lipids containing this component divided by the total abundance of all lipid molecules in this class.


## 2.1. Sample Collection of Rats and Mice

All animal experiments were conducted in accordance with the German animal welfare laws and approved by local authorities. Animals were kept on a diet based on rodent’s ssniffTM pellets “Ratte/Maus-Haltung” (ssniff-Spezialdiäten GmbH, Soest, Germany) and water ad libitum. Tissue samples of brain, heart, liver, kidney, spleen, stomach, lung, muscle, small intestine, large intestine, skin, and fat were collected from individual male Wistar rats (HsdRCCHan:Wistar, Envigo, NL; weight range: 256–302 g), female NMRI mice (Crl:NMRI BR, Charles River, Germany; weight range: 28–30 g), and female CD1 mice (Crl:CD1(Icr), Charles River, Germany; weight range: 27–31 g) with nine replicates, respectively. Solid tissues were excised, briefly washed with isotonic NaCl solution to wash off blood residues. The stomach and the intestines were additionally cleared of their content with NaCl washing solution. The whole organs were collected, except for skin (4 cm2, belly), fat (5 g, abdominal fat), and muscles (5 g, belly/leg). All samples were immediately shock frozen in liquid nitrogen after preparation.


## 2.2. Lipid Extraction from 12 Organs/Tissues of Wistar Rat and CD1 and NMRI Mice

Lipids were extracted as previously described [36]. Briefly, 50 mg wet tissue samples were homogenized in 500 μL of chloroform/methanol (v : v = 2 : 1) with an internal standard solution. Aqueous was subsequently added. Solutions were vortexed for 1-2 min and prepared for extraction with three replicates. Then, samples were centrifuged for 5 mins at 1000 rpm for phase separation. The lower organic layer was transferred using a glass syringe and dried under nitrogen. Lipid samples were stored in −80°C dry pellets. During lipid extraction, 5 mL glass tubes were used in order to avoid contamination.


## 2.3. Lipidomic Analysis Using LC-MS/MS

Reverse phase chromatography was selected for LC separation using CORTECS C18 Column (2.1 × 100 mm, Waters). Mobile phase A was made by mixing 400 mL of HPLC-grade water containing 0.77 g of ammonium acetate with 600 mL of HPLC-grade acetonitrile (pH ∼7). Mobile phase B contained 10% ACN and 90% IPA (v/v). Data was acquired using Q Exactive Orbitrap mass spectrometer (Thermo, CA) coupled with UHPLC system Ultimate 3000 (Thermo, CA). Data-dependent acquisition (DDA) was performed with 70,000 MS resolution and 17,500 MS/MS resolution. MS/MS spectra were acquired from the top 10 most intense precursors. Stepped NCE (normalized collision energy) of 15, 25, 35 was applied for fragmentation.


## 2.4. Identification of Phospholipids and Glycerolipids

Lipids were identified using LipidSearch software v4.1.16 (Thermo, CA). LipidSearch v4.1.16 has 1,500,000 fragment ions of 71 subspecies in the database. It allows lipid identification based on MS/MS match [23] and ID-based quantitation was performed. Mass tolerance of 8 ppm and 15 ppm was set for precursor and fragment, respectively. The displayed m-score threshold was selected as 5 and grades A, B, C, D were all used for ID quality filter. Adducts of +H, +NH4 were used for positive mode search and −H, +CH3COO− were chosen for negative mode. Thresholds of m-core and chromatographic peak shapes were applied to eliminate false positives.


## 2.5. Quantitation of Phospholipids and Glycerolipids

Stock solutions of 10 mg/mL PC (18 : 0/18 : 0), PE (18 : 0/18 : 0), PI (16 : 0/16 : 0), PS (16 : 0/16 : 0), PG (18 : 0/18 : 0), CL (18 : 1/18 : 1/18 : 1/18 : 1), DG (16 : 0/18 : 0), and TG (16 : 0/16 : 0/18 : 0) were prepared. Then, a series of calibration solutions, with concentrations of from 1 ng/mL up to 200µg/mL, were diluted using CH2Cl2 : MeOH = 2 : 1. Internal standard solution containing PC (14 : 0/14 : 0), PE (14 : 0/14 : 0), PI (8 : 0/8 : 0) PS (14 : 0/14 : 0), PG (14 : 0/14 : 0), CL (14 : 0/14 : 0/14 : 0/14 : 0), DG (14 : 0/14 : 0), and TG (16 : 0/16 : 0/18 : 0)-D7 were made. Equal volumes of calibration solution and internal standard solution were mixed. Injection volume of 1 µL was used for the analysis.


## 2.6. Analysis of Glycerophospholipids and Glycerolipids in Mouse Brain Tissues

C57BL/6 mice at the age of 12 and 96 weeks were dissected and lipids in frozen brain tissues were extracted according to the protocols in section2.2. Five replicates were used in the analysis. Glycerophospholipids were analyzed in negative ion mode using UHPLC-Q Exactive Orbitrap MS whereas DG and TG lipid molecules were analyzed in positive ion mode. The acyl chain component analysis was performed for each lipid class based on the abundance of lipid molecules. The abundance of lipid molecule was considered to contribute equally to each fatty acid component. Therefore, the percentage of specific acyl chain components in a certain lipid class was calculated using the total abundance of lipids containing this component divided by the total abundance of all lipid molecules in this class.


## 3. Results and Discussion

### 3.1. Analysis of Phospholipids and Glycerolipids in Mice and Rats

In this analysis, data-dependent MS/MS acquisition (DDA) was applied for lipid identification with MS-based quantitation as shown in Figure1. LipidSearch, which contains millions of predicted fragment ion information was applied to assign lipid molecules based on MS/MS fragments. However, due to the extraordinary presence of fake molecular identification using LipidSearch, the strategies to remove unreliable assignments were utilized to reduce false positive results [37]. Briefly, the chromatographic behavior and MS/MS match were evaluated for each lipid species. The molecules with poor peak shapes or low confidence of MS/MS matching score (m-score) were eliminated as false positives. However, the threshold of peak shape or m-score was unique for each lipid class depending on the data quality. Moreover, the signals from in-source decay or polymerization also had to be excluded as artificial ones, for example, dimethylated PE (dMePE) or fatty acid ester of hydroxyl fatty acid (FAHFA) [37].Figure 1
Schematic showing the workflow to perform lipidomics analysis for tissues/organs.For lipid quantitation, exogenous internal standards including PC(14 : 0/14 : 0), PE (14 : 0/14 : 0), PS (14 : 0/14 : 0), PG (14 : 0/14 : 0), CL (14 : 0/14 : 0/14 : 0/14 : 0), DG (14 : 0/14 : 0), and TG (16 : 0/16 : 0/18 : 0)-D7 were applied for quantification of each lipid class with PG (14 : 0/14 : 0) also used as an internal standard of phosphatidylinositol (PI). PC (18 : 0/18 : 0), PE (18 : 0/18 : 0), PI (16 : 0/16 : 0), PS (16 : 0/16 : 0), PG (18 : 0/18 : 0), CL (18 : 1/18 : 1/18 : 1/18 : 1), DG (16 : 0/18 : 0), and TG (16 : 0/16 : 0/18 : 0) were selected as representative molecules for quantitation. Generally, glycerolipids generate the featured fragment of the head group or neutral loss in positive mode and fatty acid fragments in ion negative mode, whereas triglyceride (TG) and diglycerides (DG) were observed to have a unique neutral loss of acyl chains in MS/MS spectra from positive ion mode, giving information of fatty acid composition (Figure S1). Therefore, phospholipids were quantified using chromatographic areas in negative ion mode since they provide the acyl chain component information, whereas TG and DG were quantified in positive ion mode. The quantitation was adjusted using the models in Figure S2 to correct for the effect of 13C heavy isotopes and response factors for various acyl chain length [38, 39].


### 3.2. Global Profiling of Phospholipids and Glycerolipids

In order to compare the strain or organ dependence of lipid constituents, phospholipids, and glycerolipids including LysoPC, LysoPE, LysoPS, PC, PE, PG, PS, PI, CL, DG, and TG in 12 organs/tissues from Wistar rats, CD1 and NMRI mice were profiled. There were 9 replicates for each organ/tissue. A total of 1144 lipid molecules from 324 tissues were confidently identified based on MS/MS spectra match and quantified using chromatographic areas of precursors. The quantitation of these 11 lipid classes in each organ/tissue is displayed in Table1. Phosphatidic acid (PA) was excluded from the analysis due to the poor linearity and chromatographic behavior in this method. Overall, organ specificity was more obvious compared to animal species dependency. Lung has the highest PG level among all the organ/tissues, whereas brain tissues contain much higher levels of PS lipids in all animals. Notably, the most abundant lysophospholipid levels were observed in the stomach, especially for lysophosphatidylcholine. It has been known that lysophospholipids facilitate fat emulsion and nutrient absorption in the digestive system. Therefore, high levels of lysophospholipids in the stomach may be related to the unique function of these lipid molecules. In order to use the results as input into tissue composition-based equations of PBPK models [40], the lipids were classified as acidic phospholipids (CL, PG, PI, and PS), neutral phospholipids (LPC, PC, LPE, and PE), and neutral lipids (DG and TG) and the amounts were calculated by the sum of corresponding lipid levels as listed in Table 1. However, in our measurement, the brain has the most abundant acidic phospholipids in all three animal species due to its high level of PS.Table 1
Quantitation of 11 lipid classes in 12 organs/tissues from CD1 mice, NMRI mice, and Wistar rats.
Animal speciesCD1 miceNMRI miceRatCD1 miceNMRI miceRatCD1 miceNMRI miceRatCD1 miceNMRI miceRat(a) Includes the data from brain, fat, heart, and kidneyOrgansBrainFatHeartKidneyCL470.0 ± 63.0197.8 ± 36.5168.4 ± 10.98.4 ± 3.611.5 ± 7.43.2 ± 1.2252.6 ± 19.8220.7 ± 17.8381.9 ± 32.5458.0 ± 33.6257.5 ± 9.2444.6 ± 35.7LPC16.1 ± 2.317.0 ± 3.435.7 ± 5.02.1 ± 1.313.5 ± 9.02.5 ± 1.493.2 ± 12.2115.5 ± 23.660.6 ± 22.855.2 ± 8.566.2 ± 6.231.2 ± 1.7LPE8.0 ± 1.920.4 ± 4.38.9 ± 1.60.8 ± 0.77.9 ± 8.1n.d. ± n.d.43.2 ± 4.857.0 ± 12.944.2 ± 22.048.0 ± 5.250.0 ± 7.724.8 ± 3.1LPSn.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.PC4079.0 ± 218.92908.9 ± 375.94912.5 ± 442.5210.7 ± 36.2436.5 ± 139.1426.4 ± 66.62469.4 ± 125.02368.0 ± 121.14007.6 ± 244.63322.6 ± 245.93192.4 ± 68.42966.7 ± 169.7PE5120.3 ± 267.56704.8 ± 1142.413374.3 ± 556.7189.2 ± 53.6433.1 ± 135.7246.2 ± 44.91635.3 ± 118.71638.6 ± 114.93613.5 ± 238.63377.3 ± 156.72500.0 ± 152.15495.7 ± 333.7PG95.0 ± 4.773.6 ± 6.850.4 ± 3.80.2 ± 0.23.4 ± 2.00.2 ± 0.161.8 ± 6.944.1 ± 5.449.2 ± 5.7161.7 ± 32.173.9 ± 8.630.7 ± 2.2PI294.2 ± 22.9235.5 ± 28.2194.0 ± 10.116.0 ± 5.619.1 ± 8.28.7 ± 3.389.9 ± 8.145.0 ± 5.635.5 ± 4.6405.8 ± 47.1126.8 ± 9.6167.4 ± 7.8PS1244.6 ± 41.41179.6 ± 87.71831.2 ± 137.059.3 ± 12.168.0 ± 12.824.5 ± 8.178.0 ± 7.444.8 ± 9.071.0 ± 15.0462.9 ± 33.9333.6 ± 38.2606.9 ± 21.0DG20.7 ± 5.513.0 ± 4.0155.1 ± 61.7133.8 ± 23.592.9 ± 10.0262.6 ± 36.09.9 ± 5.43.6 ± 1.147.3 ± 8.614.6 ± 2.78.1 ± 0.942.6 ± 6.8TG3.4 ± 1.526.9 ± 23.328.0 ± 10.25073.4 ± 879.53093.1 ± 308.519115.4 ± 3094.0292.7 ± 99.0110.8 ± 82.7490.0 ± 248.2231.7 ± 92.0167.4 ± 53.0298.8 ± 73.4Acidic phospholipids2103.81686.62244.183.9101.936.6482.4354.6537.71488.4791.71249.6Neutral phospholipids9223.49651.118331.3402.7891.0675.14241.14179.17725.96803.15808.58518.4Neutral lipids24.139.9183.15207.23186.119378.0302.6114.4537.3246.3175.5341.4(b) Includes the data from L-intestine, liver, lung, and muscleOrgansL-intestineLiverLungMuscleCL97.2 ± 18.077.2 ± 10.164.2 ± 9.2164.1 ± 25.3151.6 ± 9.8282.4 ± 39.235.8 ± 3.510.4 ± 1.628.7 ± 9.679.8 ± 6.455.5 ± 6.6123.7 ± 17.6LPC73.7 ± 12.0113.6 ± 36.5101.8 ± 20.0111.5 ± 25.2192.7 ± 94.5102.7 ± 39.415.9 ± 3.128.2 ± 6.27.9 ± 2.053.8 ± 14.622.8 ± 6.487.9 ± 36.4LPE47.8 ± 10.2103.4 ± 27.117.2 ± 7.927.8 ± 9.898.8 ± 54.911.8 ± 7.310.7 ± 0.924.1 ± 6.6n.d. ± n.d.14.8 ± 5.66.6 ± 2.321.1 ± 13.8LPSn.d. ± n.d.n.d. ± n.d.0.2 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.PC1728.9 ± 196.62329.0 ± 268.01977.2 ± 157.73209.5 ± 183.63795.9 ± 902.66245.5 ± 438.0517.8 ± 40.8855.0 ± 78.5624.0 ± 191.71871.5 ± 151.31287.8 ± 84.96463.1 ± 382.7PE1546.7 ± 177.82882.2 ± 370.42463.5 ± 333.42260.5 ± 118.61942.5 ± 449.94535.3 ± 270.01511.3 ± 55.81647.3 ± 238.22658.6 ± 687.51862.0 ± 169.61471.3 ± 135.53341.1 ± 164.8PG38.8 ± 7.129.3 ± 3.615.9 ± 2.130.9 ± 9.647.7 ± 2.420.2 ± 2.6449.6 ± 48.5216.2 ± 28.4165.4 ± 72.823.4 ± 4.015.0 ± 2.612.3 ± 1.3PI146.5 ± 22.0120.9 ± 12.474.3 ± 12.3104.6 ± 25.2129.5 ± 7.8166.1 ± 26.3157.9 ± 8.143.1 ± 7.041.9 ± 18.047.3 ± 8.135.3 ± 7.130.6 ± 4.2PS278.3 ± 29.3323.9 ± 43.1138.2 ± 11.6203.3 ± 41.1124.6 ± 23.7260.7 ± 113.0555.9 ± 28.3171.6 ± 25.4381.8 ± 174.670.9 ± 8.165.0 ± 9.554.3 ± 5.9DG29.7 ± 5.124.9 ± 7.951.6 ± 9.557.8 ± 11.257.2 ± 18.4101.2 ± 20.625.3 ± 3.416.7 ± 2.271.6 ± 19.38.3 ± 2.311.6 ± 3.667.8 ± 40.6TG1084.7 ± 288.11286.6 ± 475.62423.6 ± 1000.5392.4 ± 96.9734.6 ± 161.0602.5 ± 207.8323.1 ± 54.3279.5 ± 92.0164.5 ± 66.71894.2 ± 258.9815.7 ± 277.92110.8 ± 1380.0Acidic phospholipids560.8551.4292.8502.9453.4729.31199.2441.5617.8221.4170.9220.8Neutral phospholipids3397.15428.24559.75609.46030.010895.42055.82554.63290.63802.12788.59913.2Neutral lipids1114.41311.42475.2450.2791.8703.7348.4296.2236.11902.5827.32178.6(c) Includes the data from S-intestine, skin, spleen, and stomachOrgansS-intestineSkinSpleenStomachCL91.5 ± 17.923.1 ± 9.760.9 ± 21.020.3 ± 4.013.2 ± 1.718.3 ± 3.857.7 ± 5.929.7 ± 1.735.3 ± 2.544.0 ± 21.86.0 ± 2.612.7 ± 3.4LPC47.7 ± 14.371.5 ± 38.387.5 ± 34.99.4 ± 1.613.4 ± 2.17.1 ± 0.927.7 ± 6.527.5 ± 3.924.8 ± 3.0329.7 ± 150.5256.6 ± 86.6218.0 ± 35.2LPE51.1 ± 25.4111.9 ± 30.445.5 ± 21.21.9 ± 0.93.4 ± 0.61.0 ± 0.710.6 ± 2.018.2 ± 2.63.4 ± 0.9272.3 ± 105.9145.1 ± 56.924.0 ± 2.8LPSn.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.225.8 ± 66.023.5 ± 6.85.5 ± 2.1PC1754.5 ± 222.9937.6 ± 350.32402.0 ± 1130.7413.8 ± 82.5691.4 ± 45.51075.8 ± 109.52084.8 ± 58.31613.7 ± 58.81670.9 ± 121.31642.8 ± 309.9812.5 ± 158.7879.8 ± 45.9PE1419.6 ± 184.6589.4 ± 172.21865.2 ± 388.3300.5 ± 30.7549.4 ± 29.0630.8 ± 72.01356.9 ± 60.71238.4 ± 74.11769.8 ± 50.51122.0 ± 235.3582.6 ± 118.91203.4 ± 138.8PG70.9 ± 18.125.1 ± 13.17.8 ± 3.410.5 ± 2.146.2 ± 0.82.5 ± 0.437.1 ± 2.835.9 ± 2.729.9 ± 4.122.3 ± 4.816.0 ± 4.13.6 ± 0.9PI165.9 ± 29.952.1 ± 20.127.0 ± 11.744.2 ± 5.530.0 ± 2.216.1 ± 2.783.0 ± 11.352.8 ± 6.541.4 ± 3.887.2 ± 16.055.3 ± 8.914.9 ± 4.9PS231.0 ± 56.574.6 ± 15.6106.0 ± 31.198.9 ± 12.89.1 ± 6.817.3 ± 3.7298.6 ± 25.2195.1 ± 25.8246.1 ± 40.984.9 ± 22.347.4 ± 10.837.0 ± 9.0DG30.8 ± 6.513.6 ± 3.4235.3 ± 87.312.9 ± 3.217.5 ± 2.260.7 ± 17.35.7 ± 1.54.0 ± 0.69.7 ± 0.925.3 ± 6.711.6 ± 3.327.7 ± 4.9TG616.1 ± 409.5343.9 ± 233.2964.7 ± 544.71316.8 ± 230.51270.5 ± 192.64080.5 ± 1091.7127.7 ± 76.137.8 ± 20.0133.1 ± 101.7589.4 ± 288.4328.2 ± 183.31365.5 ± 395.1Acidic phospholipids559.4174.9201.7173.9138.654.3476.4313.5352.7464.2148.173.7Neutral phospholipids3272.91710.44400.2725.61257.61714.73480.12897.83468.93366.81796.92325.3Neutral lipids647.0357.51199.91329.81288.04141.3133.441.8142.7614.7339.71393.3The unit of all the measurements is ng/mg organ/tissue. Nine replicates were used for measurement.


### 3.3. Acyl Chain Components in Phospholipids and Glycerolipids

All phospholipids and glycerolipids were composed of acyl chains with diverse chain length and double bonds. It has been proposed that the acyl chain composition may play a biological function due to the diverse structures [41, 42]. In our method, the fatty acid compositions of phospholipids and glycerolipids in animal organs/tissues were able to be profiled and compared. Figure 2 demonstrates the acyl chain compositions of PC, PE, PS, PG, PI, CL, DG, and TG in 12 organs/tissues of CD1 and NMRI mice as well as Wistar rats. The acyl chains with less than 1% were not included in the figures for better visualization. Clearly, animal strain specificity was rarely observed among these three animals for most lipids. The heatmaps in Figure 3 confirmed the clustering of fatty acid constituents in 12 organs/tissues of three animal strains. More obvious animal strain similarity was observed based on the clustering results, in which muscle, skin, heart, liver, and fat tissues are more alike. Among all the organs/tissues, heart and liver are highly similar in fatty acid components.Figure 2
Acyl chain percentage compositions of PE, PC, PI, PG, PS, CL, DG, and TG in 12 organs/tissues of CD1, NMRI mice, and rats (n = 9). Each color represents a different fatty acid chain. The acyl chains with less than 1% were not included in the figures for better visualization.
(a)(b)Figure 3
Heatmap clustering of fatty acid constituents in 12 organs/tissues of CD1 and NMRI mice and rats (n = 9). Analysis was performed using MetaboAnalyst (http://www.metaboanalyst.ca). Distance measure of Elucidation and clustering algorithm of Ward were applied in the analysis.However, a certain animal strain dependency of acyl chain components was seen for some lipid species. Phosphatidylcholine (PC) and phosphatidylglycerol (PG) tended to incorporate more FA (22 : 6) in CD1 and NMRI mice compared to Wistar rats, especially for brain, heart, small intestine, stomach, and liver (Figures4(a) and 4(b)). In contrast, triglycerides in Wistar rats had more preference of FA (18 : 3) compared to CD1 and NMRI mice (Figure 4(c)). In Figure 2, the similarity of acyl chain constituents among different organs/tissues was observed with the exception of the brain. FA (18 : 2) is extremely unfavored in brain tissue for all phospholipids and diglycerides. Although FA (18 : 2) accounts for about 70% of the cardiolipin acyl components in all other tissues, the brain only contains ∼7% of FA (18 : 2) and favors FA (18 : 1) and FA (20 : 4) instead (Figure 4(d)).Figure 4
Percentage contribution of (a) acyl chain FA(22 : 6) in PC, (b) acyl chain FA(22 : 6) in PG, (c) acyl chain FA(18 : 3) in TG, and (d) acyl chain FA(18 : 2) in CL in 12 organs/tissues of CD1 and NMRI mice and rats (n = 9).
(a)(b)(c)(d)Lipid remodeling is a well-known strategy to help the lipids adapt a specific biological function in various organs/tissues. Unlike the symmetric structure of cardiolipin with dominant FA (18 : 2) in mouse heart, liver, and muscle, a more diverse acyl chain composition has been reported in brain tissue [43, 44]. Our profiling results demonstrate consistent observation and conclude that the brain is the only exceptional organ among all 12 organs/tissues. It has been hypothesized that the diversified fatty acid composition in cardiolipins is related to the reduced mitochondrial bioenergetic efficiency in the brain [43, 45]. However, the overall unfavored incorporation of FA (18 : 2) was observed in most lipids except triglycerides (Figure 2). Free fatty acids were analyzed in all tissues/organs of the rodent species/strains tested. A relative abundance of free FA (18 : 2) in brain tissues was lower by at least an order of magnitude compared to all other tissues (Figure S3). Therefore, the composition of free fatty acids in the brain may be the result of unfavored incorporation of FA (18 : 2) in phospholipids and glycerolipids after lipid remodeling. Notably, the acyl chain components in triglycerides are distinct from the ones in diglycerides due to the lipid remodeling process [46]. FA (18 : 0) and FA (20 : 4) contents were highly reduced in triglycerides, indicating scarce usage of these two fatty acids as energy store.


### 3.4. Analysis of Ether Lipids in 12 Organs/Tissues of Rats and Mice

Ether lipids refer to the phospholipid molecules with an alkyl or alkenyl chain attached to an ether bond instead of an acyl chain at sn-1 position. Two types of ether lipids, plasmanyl- and plasmenyl-phospholipids, exist in mammalian cells and animals [47, 48]. Plasmanyl-phospholipids carry the ether bond at an alkyl group, whereas plasmenyl-phospholipids contain the ether bond at an alkenyl group at sn-1 position. Plasmenyl-phospholipids, normally called plasmalogens, can protect from cellular damage due to reactive oxygen species (ROS) and play a role in cell signaling processes [5, 49]. The most common ether lipids are plasmanyl- and plasmenyl-phosphatidylcholines (referred to as ePC) and phosphatidylethanolamines (referred to as ePE).The amounts of ether lipids were quantified in 12 organs/tissues from Wistar rats and CD1 and NMRI mice as displayed in Figure5. Although organ/tissue specificity was observed, high similarity within animal strains was found for the distribution of ether lipids in general. Apparently, among all the organs/tissues, brain contains the highest levels of ePEs. Only weak species differences were observed for ether lipid distribution among 12 organs/tissues, with CD1 mice containing much fewer ether lipids compared to NMRI mice and Wistar rats.Figure 5
Absolute amounts of ether lipids as quantified in 12 organs/tissues from CD1 and NMRI mice and rats (n = 9).
(a)(b)(c)


### 3.5. Analysis of Acyl Chain Components in Brain Tissue of Aged Mice

Using the method established above, the acyl chain constituents of phospholipids and glycerolipids in brain tissues of aged mice are analyzed inFigure S4. The percentage of acyl chain composition was calculated based on each lipid species. The results indicated that FA (16 : 1) in PI, FA (17 : 0) in PG, and FA (16 : 1e) in PE had less percentage contribution in mice brain of 2 years old. However, FA (18 : 2e) in PE, FA (22 : 6) in PG, and FA (19 : 0) in TG had higher incorporation level in lipids in aged mice brain.


## 3.1. Analysis of Phospholipids and Glycerolipids in Mice and Rats

In this analysis, data-dependent MS/MS acquisition (DDA) was applied for lipid identification with MS-based quantitation as shown in Figure1. LipidSearch, which contains millions of predicted fragment ion information was applied to assign lipid molecules based on MS/MS fragments. However, due to the extraordinary presence of fake molecular identification using LipidSearch, the strategies to remove unreliable assignments were utilized to reduce false positive results [37]. Briefly, the chromatographic behavior and MS/MS match were evaluated for each lipid species. The molecules with poor peak shapes or low confidence of MS/MS matching score (m-score) were eliminated as false positives. However, the threshold of peak shape or m-score was unique for each lipid class depending on the data quality. Moreover, the signals from in-source decay or polymerization also had to be excluded as artificial ones, for example, dimethylated PE (dMePE) or fatty acid ester of hydroxyl fatty acid (FAHFA) [37].Figure 1
Schematic showing the workflow to perform lipidomics analysis for tissues/organs.For lipid quantitation, exogenous internal standards including PC(14 : 0/14 : 0), PE (14 : 0/14 : 0), PS (14 : 0/14 : 0), PG (14 : 0/14 : 0), CL (14 : 0/14 : 0/14 : 0/14 : 0), DG (14 : 0/14 : 0), and TG (16 : 0/16 : 0/18 : 0)-D7 were applied for quantification of each lipid class with PG (14 : 0/14 : 0) also used as an internal standard of phosphatidylinositol (PI). PC (18 : 0/18 : 0), PE (18 : 0/18 : 0), PI (16 : 0/16 : 0), PS (16 : 0/16 : 0), PG (18 : 0/18 : 0), CL (18 : 1/18 : 1/18 : 1/18 : 1), DG (16 : 0/18 : 0), and TG (16 : 0/16 : 0/18 : 0) were selected as representative molecules for quantitation. Generally, glycerolipids generate the featured fragment of the head group or neutral loss in positive mode and fatty acid fragments in ion negative mode, whereas triglyceride (TG) and diglycerides (DG) were observed to have a unique neutral loss of acyl chains in MS/MS spectra from positive ion mode, giving information of fatty acid composition (Figure S1). Therefore, phospholipids were quantified using chromatographic areas in negative ion mode since they provide the acyl chain component information, whereas TG and DG were quantified in positive ion mode. The quantitation was adjusted using the models in Figure S2 to correct for the effect of 13C heavy isotopes and response factors for various acyl chain length [38, 39].


## 3.2. Global Profiling of Phospholipids and Glycerolipids

In order to compare the strain or organ dependence of lipid constituents, phospholipids, and glycerolipids including LysoPC, LysoPE, LysoPS, PC, PE, PG, PS, PI, CL, DG, and TG in 12 organs/tissues from Wistar rats, CD1 and NMRI mice were profiled. There were 9 replicates for each organ/tissue. A total of 1144 lipid molecules from 324 tissues were confidently identified based on MS/MS spectra match and quantified using chromatographic areas of precursors. The quantitation of these 11 lipid classes in each organ/tissue is displayed in Table1. Phosphatidic acid (PA) was excluded from the analysis due to the poor linearity and chromatographic behavior in this method. Overall, organ specificity was more obvious compared to animal species dependency. Lung has the highest PG level among all the organ/tissues, whereas brain tissues contain much higher levels of PS lipids in all animals. Notably, the most abundant lysophospholipid levels were observed in the stomach, especially for lysophosphatidylcholine. It has been known that lysophospholipids facilitate fat emulsion and nutrient absorption in the digestive system. Therefore, high levels of lysophospholipids in the stomach may be related to the unique function of these lipid molecules. In order to use the results as input into tissue composition-based equations of PBPK models [40], the lipids were classified as acidic phospholipids (CL, PG, PI, and PS), neutral phospholipids (LPC, PC, LPE, and PE), and neutral lipids (DG and TG) and the amounts were calculated by the sum of corresponding lipid levels as listed in Table 1. However, in our measurement, the brain has the most abundant acidic phospholipids in all three animal species due to its high level of PS.Table 1
Quantitation of 11 lipid classes in 12 organs/tissues from CD1 mice, NMRI mice, and Wistar rats.
Animal speciesCD1 miceNMRI miceRatCD1 miceNMRI miceRatCD1 miceNMRI miceRatCD1 miceNMRI miceRat(a) Includes the data from brain, fat, heart, and kidneyOrgansBrainFatHeartKidneyCL470.0 ± 63.0197.8 ± 36.5168.4 ± 10.98.4 ± 3.611.5 ± 7.43.2 ± 1.2252.6 ± 19.8220.7 ± 17.8381.9 ± 32.5458.0 ± 33.6257.5 ± 9.2444.6 ± 35.7LPC16.1 ± 2.317.0 ± 3.435.7 ± 5.02.1 ± 1.313.5 ± 9.02.5 ± 1.493.2 ± 12.2115.5 ± 23.660.6 ± 22.855.2 ± 8.566.2 ± 6.231.2 ± 1.7LPE8.0 ± 1.920.4 ± 4.38.9 ± 1.60.8 ± 0.77.9 ± 8.1n.d. ± n.d.43.2 ± 4.857.0 ± 12.944.2 ± 22.048.0 ± 5.250.0 ± 7.724.8 ± 3.1LPSn.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.PC4079.0 ± 218.92908.9 ± 375.94912.5 ± 442.5210.7 ± 36.2436.5 ± 139.1426.4 ± 66.62469.4 ± 125.02368.0 ± 121.14007.6 ± 244.63322.6 ± 245.93192.4 ± 68.42966.7 ± 169.7PE5120.3 ± 267.56704.8 ± 1142.413374.3 ± 556.7189.2 ± 53.6433.1 ± 135.7246.2 ± 44.91635.3 ± 118.71638.6 ± 114.93613.5 ± 238.63377.3 ± 156.72500.0 ± 152.15495.7 ± 333.7PG95.0 ± 4.773.6 ± 6.850.4 ± 3.80.2 ± 0.23.4 ± 2.00.2 ± 0.161.8 ± 6.944.1 ± 5.449.2 ± 5.7161.7 ± 32.173.9 ± 8.630.7 ± 2.2PI294.2 ± 22.9235.5 ± 28.2194.0 ± 10.116.0 ± 5.619.1 ± 8.28.7 ± 3.389.9 ± 8.145.0 ± 5.635.5 ± 4.6405.8 ± 47.1126.8 ± 9.6167.4 ± 7.8PS1244.6 ± 41.41179.6 ± 87.71831.2 ± 137.059.3 ± 12.168.0 ± 12.824.5 ± 8.178.0 ± 7.444.8 ± 9.071.0 ± 15.0462.9 ± 33.9333.6 ± 38.2606.9 ± 21.0DG20.7 ± 5.513.0 ± 4.0155.1 ± 61.7133.8 ± 23.592.9 ± 10.0262.6 ± 36.09.9 ± 5.43.6 ± 1.147.3 ± 8.614.6 ± 2.78.1 ± 0.942.6 ± 6.8TG3.4 ± 1.526.9 ± 23.328.0 ± 10.25073.4 ± 879.53093.1 ± 308.519115.4 ± 3094.0292.7 ± 99.0110.8 ± 82.7490.0 ± 248.2231.7 ± 92.0167.4 ± 53.0298.8 ± 73.4Acidic phospholipids2103.81686.62244.183.9101.936.6482.4354.6537.71488.4791.71249.6Neutral phospholipids9223.49651.118331.3402.7891.0675.14241.14179.17725.96803.15808.58518.4Neutral lipids24.139.9183.15207.23186.119378.0302.6114.4537.3246.3175.5341.4(b) Includes the data from L-intestine, liver, lung, and muscleOrgansL-intestineLiverLungMuscleCL97.2 ± 18.077.2 ± 10.164.2 ± 9.2164.1 ± 25.3151.6 ± 9.8282.4 ± 39.235.8 ± 3.510.4 ± 1.628.7 ± 9.679.8 ± 6.455.5 ± 6.6123.7 ± 17.6LPC73.7 ± 12.0113.6 ± 36.5101.8 ± 20.0111.5 ± 25.2192.7 ± 94.5102.7 ± 39.415.9 ± 3.128.2 ± 6.27.9 ± 2.053.8 ± 14.622.8 ± 6.487.9 ± 36.4LPE47.8 ± 10.2103.4 ± 27.117.2 ± 7.927.8 ± 9.898.8 ± 54.911.8 ± 7.310.7 ± 0.924.1 ± 6.6n.d. ± n.d.14.8 ± 5.66.6 ± 2.321.1 ± 13.8LPSn.d. ± n.d.n.d. ± n.d.0.2 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.PC1728.9 ± 196.62329.0 ± 268.01977.2 ± 157.73209.5 ± 183.63795.9 ± 902.66245.5 ± 438.0517.8 ± 40.8855.0 ± 78.5624.0 ± 191.71871.5 ± 151.31287.8 ± 84.96463.1 ± 382.7PE1546.7 ± 177.82882.2 ± 370.42463.5 ± 333.42260.5 ± 118.61942.5 ± 449.94535.3 ± 270.01511.3 ± 55.81647.3 ± 238.22658.6 ± 687.51862.0 ± 169.61471.3 ± 135.53341.1 ± 164.8PG38.8 ± 7.129.3 ± 3.615.9 ± 2.130.9 ± 9.647.7 ± 2.420.2 ± 2.6449.6 ± 48.5216.2 ± 28.4165.4 ± 72.823.4 ± 4.015.0 ± 2.612.3 ± 1.3PI146.5 ± 22.0120.9 ± 12.474.3 ± 12.3104.6 ± 25.2129.5 ± 7.8166.1 ± 26.3157.9 ± 8.143.1 ± 7.041.9 ± 18.047.3 ± 8.135.3 ± 7.130.6 ± 4.2PS278.3 ± 29.3323.9 ± 43.1138.2 ± 11.6203.3 ± 41.1124.6 ± 23.7260.7 ± 113.0555.9 ± 28.3171.6 ± 25.4381.8 ± 174.670.9 ± 8.165.0 ± 9.554.3 ± 5.9DG29.7 ± 5.124.9 ± 7.951.6 ± 9.557.8 ± 11.257.2 ± 18.4101.2 ± 20.625.3 ± 3.416.7 ± 2.271.6 ± 19.38.3 ± 2.311.6 ± 3.667.8 ± 40.6TG1084.7 ± 288.11286.6 ± 475.62423.6 ± 1000.5392.4 ± 96.9734.6 ± 161.0602.5 ± 207.8323.1 ± 54.3279.5 ± 92.0164.5 ± 66.71894.2 ± 258.9815.7 ± 277.92110.8 ± 1380.0Acidic phospholipids560.8551.4292.8502.9453.4729.31199.2441.5617.8221.4170.9220.8Neutral phospholipids3397.15428.24559.75609.46030.010895.42055.82554.63290.63802.12788.59913.2Neutral lipids1114.41311.42475.2450.2791.8703.7348.4296.2236.11902.5827.32178.6(c) Includes the data from S-intestine, skin, spleen, and stomachOrgansS-intestineSkinSpleenStomachCL91.5 ± 17.923.1 ± 9.760.9 ± 21.020.3 ± 4.013.2 ± 1.718.3 ± 3.857.7 ± 5.929.7 ± 1.735.3 ± 2.544.0 ± 21.86.0 ± 2.612.7 ± 3.4LPC47.7 ± 14.371.5 ± 38.387.5 ± 34.99.4 ± 1.613.4 ± 2.17.1 ± 0.927.7 ± 6.527.5 ± 3.924.8 ± 3.0329.7 ± 150.5256.6 ± 86.6218.0 ± 35.2LPE51.1 ± 25.4111.9 ± 30.445.5 ± 21.21.9 ± 0.93.4 ± 0.61.0 ± 0.710.6 ± 2.018.2 ± 2.63.4 ± 0.9272.3 ± 105.9145.1 ± 56.924.0 ± 2.8LPSn.d. ± n.d.n.d. ± n.d.0.1 ± 0.0n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.n.d. ± n.d.225.8 ± 66.023.5 ± 6.85.5 ± 2.1PC1754.5 ± 222.9937.6 ± 350.32402.0 ± 1130.7413.8 ± 82.5691.4 ± 45.51075.8 ± 109.52084.8 ± 58.31613.7 ± 58.81670.9 ± 121.31642.8 ± 309.9812.5 ± 158.7879.8 ± 45.9PE1419.6 ± 184.6589.4 ± 172.21865.2 ± 388.3300.5 ± 30.7549.4 ± 29.0630.8 ± 72.01356.9 ± 60.71238.4 ± 74.11769.8 ± 50.51122.0 ± 235.3582.6 ± 118.91203.4 ± 138.8PG70.9 ± 18.125.1 ± 13.17.8 ± 3.410.5 ± 2.146.2 ± 0.82.5 ± 0.437.1 ± 2.835.9 ± 2.729.9 ± 4.122.3 ± 4.816.0 ± 4.13.6 ± 0.9PI165.9 ± 29.952.1 ± 20.127.0 ± 11.744.2 ± 5.530.0 ± 2.216.1 ± 2.783.0 ± 11.352.8 ± 6.541.4 ± 3.887.2 ± 16.055.3 ± 8.914.9 ± 4.9PS231.0 ± 56.574.6 ± 15.6106.0 ± 31.198.9 ± 12.89.1 ± 6.817.3 ± 3.7298.6 ± 25.2195.1 ± 25.8246.1 ± 40.984.9 ± 22.347.4 ± 10.837.0 ± 9.0DG30.8 ± 6.513.6 ± 3.4235.3 ± 87.312.9 ± 3.217.5 ± 2.260.7 ± 17.35.7 ± 1.54.0 ± 0.69.7 ± 0.925.3 ± 6.711.6 ± 3.327.7 ± 4.9TG616.1 ± 409.5343.9 ± 233.2964.7 ± 544.71316.8 ± 230.51270.5 ± 192.64080.5 ± 1091.7127.7 ± 76.137.8 ± 20.0133.1 ± 101.7589.4 ± 288.4328.2 ± 183.31365.5 ± 395.1Acidic phospholipids559.4174.9201.7173.9138.654.3476.4313.5352.7464.2148.173.7Neutral phospholipids3272.91710.44400.2725.61257.61714.73480.12897.83468.93366.81796.92325.3Neutral lipids647.0357.51199.91329.81288.04141.3133.441.8142.7614.7339.71393.3The unit of all the measurements is ng/mg organ/tissue. Nine replicates were used for measurement.


## 3.3. Acyl Chain Components in Phospholipids and Glycerolipids

All phospholipids and glycerolipids were composed of acyl chains with diverse chain length and double bonds. It has been proposed that the acyl chain composition may play a biological function due to the diverse structures [41, 42]. In our method, the fatty acid compositions of phospholipids and glycerolipids in animal organs/tissues were able to be profiled and compared. Figure 2 demonstrates the acyl chain compositions of PC, PE, PS, PG, PI, CL, DG, and TG in 12 organs/tissues of CD1 and NMRI mice as well as Wistar rats. The acyl chains with less than 1% were not included in the figures for better visualization. Clearly, animal strain specificity was rarely observed among these three animals for most lipids. The heatmaps in Figure 3 confirmed the clustering of fatty acid constituents in 12 organs/tissues of three animal strains. More obvious animal strain similarity was observed based on the clustering results, in which muscle, skin, heart, liver, and fat tissues are more alike. Among all the organs/tissues, heart and liver are highly similar in fatty acid components.Figure 2
Acyl chain percentage compositions of PE, PC, PI, PG, PS, CL, DG, and TG in 12 organs/tissues of CD1, NMRI mice, and rats (n = 9). Each color represents a different fatty acid chain. The acyl chains with less than 1% were not included in the figures for better visualization.
(a)(b)Figure 3
Heatmap clustering of fatty acid constituents in 12 organs/tissues of CD1 and NMRI mice and rats (n = 9). Analysis was performed using MetaboAnalyst (http://www.metaboanalyst.ca). Distance measure of Elucidation and clustering algorithm of Ward were applied in the analysis.However, a certain animal strain dependency of acyl chain components was seen for some lipid species. Phosphatidylcholine (PC) and phosphatidylglycerol (PG) tended to incorporate more FA (22 : 6) in CD1 and NMRI mice compared to Wistar rats, especially for brain, heart, small intestine, stomach, and liver (Figures4(a) and 4(b)). In contrast, triglycerides in Wistar rats had more preference of FA (18 : 3) compared to CD1 and NMRI mice (Figure 4(c)). In Figure 2, the similarity of acyl chain constituents among different organs/tissues was observed with the exception of the brain. FA (18 : 2) is extremely unfavored in brain tissue for all phospholipids and diglycerides. Although FA (18 : 2) accounts for about 70% of the cardiolipin acyl components in all other tissues, the brain only contains ∼7% of FA (18 : 2) and favors FA (18 : 1) and FA (20 : 4) instead (Figure 4(d)).Figure 4
Percentage contribution of (a) acyl chain FA(22 : 6) in PC, (b) acyl chain FA(22 : 6) in PG, (c) acyl chain FA(18 : 3) in TG, and (d) acyl chain FA(18 : 2) in CL in 12 organs/tissues of CD1 and NMRI mice and rats (n = 9).
(a)(b)(c)(d)Lipid remodeling is a well-known strategy to help the lipids adapt a specific biological function in various organs/tissues. Unlike the symmetric structure of cardiolipin with dominant FA (18 : 2) in mouse heart, liver, and muscle, a more diverse acyl chain composition has been reported in brain tissue [43, 44]. Our profiling results demonstrate consistent observation and conclude that the brain is the only exceptional organ among all 12 organs/tissues. It has been hypothesized that the diversified fatty acid composition in cardiolipins is related to the reduced mitochondrial bioenergetic efficiency in the brain [43, 45]. However, the overall unfavored incorporation of FA (18 : 2) was observed in most lipids except triglycerides (Figure 2). Free fatty acids were analyzed in all tissues/organs of the rodent species/strains tested. A relative abundance of free FA (18 : 2) in brain tissues was lower by at least an order of magnitude compared to all other tissues (Figure S3). Therefore, the composition of free fatty acids in the brain may be the result of unfavored incorporation of FA (18 : 2) in phospholipids and glycerolipids after lipid remodeling. Notably, the acyl chain components in triglycerides are distinct from the ones in diglycerides due to the lipid remodeling process [46]. FA (18 : 0) and FA (20 : 4) contents were highly reduced in triglycerides, indicating scarce usage of these two fatty acids as energy store.


## 3.4. Analysis of Ether Lipids in 12 Organs/Tissues of Rats and Mice

Ether lipids refer to the phospholipid molecules with an alkyl or alkenyl chain attached to an ether bond instead of an acyl chain at sn-1 position. Two types of ether lipids, plasmanyl- and plasmenyl-phospholipids, exist in mammalian cells and animals [47, 48]. Plasmanyl-phospholipids carry the ether bond at an alkyl group, whereas plasmenyl-phospholipids contain the ether bond at an alkenyl group at sn-1 position. Plasmenyl-phospholipids, normally called plasmalogens, can protect from cellular damage due to reactive oxygen species (ROS) and play a role in cell signaling processes [5, 49]. The most common ether lipids are plasmanyl- and plasmenyl-phosphatidylcholines (referred to as ePC) and phosphatidylethanolamines (referred to as ePE).The amounts of ether lipids were quantified in 12 organs/tissues from Wistar rats and CD1 and NMRI mice as displayed in Figure5. Although organ/tissue specificity was observed, high similarity within animal strains was found for the distribution of ether lipids in general. Apparently, among all the organs/tissues, brain contains the highest levels of ePEs. Only weak species differences were observed for ether lipid distribution among 12 organs/tissues, with CD1 mice containing much fewer ether lipids compared to NMRI mice and Wistar rats.Figure 5
Absolute amounts of ether lipids as quantified in 12 organs/tissues from CD1 and NMRI mice and rats (n = 9).
(a)(b)(c)


## 3.5. Analysis of Acyl Chain Components in Brain Tissue of Aged Mice

Using the method established above, the acyl chain constituents of phospholipids and glycerolipids in brain tissues of aged mice are analyzed inFigure S4. The percentage of acyl chain composition was calculated based on each lipid species. The results indicated that FA (16 : 1) in PI, FA (17 : 0) in PG, and FA (16 : 1e) in PE had less percentage contribution in mice brain of 2 years old. However, FA (18 : 2e) in PE, FA (22 : 6) in PG, and FA (19 : 0) in TG had higher incorporation level in lipids in aged mice brain.


## 4. Conclusion

In this work, we profiled the phospholipids and glycerolipids in 12 organs/tissues from Wistar rat and CD1 and NMRI mice. The high resolution MS/MS fragments were applied to assign the fatty acid component of lipid molecule and strategies to reduce false positive identifications were used to eliminate unreliable results. A total of 1144 lipids belonging to LysoPC, LysoPE, LysoPS, PC, PE, PG, PS, PI, CL, DG, and TG class were reliably identified and relatively quantified. Organ dependency of phospholipids and glycerolipids was observed in all three animal species/stains examined. The acyl chain components in 12 organs/tissues of mice and rats also revealed that each lipid class has a unique pattern of fatty acid compositions. However, rare animal species specificity was observed except for FA (22 : 6) in PC and PG. An unfavored FA (18 : 2) incorporation in phospholipids, especially in cardiolipins was observed in brain tissue. The analysis of free fatty acids turned out that the deficiency of FA (18 : 2) in brain tissues may be caused by the access of this FF. The plasmenyl-phosphatidylethanolamines (ePEs) were the most abundant ether lipids in all organs/tissues, with the brain containing the highest levels of ePEs. This supports the potential function of ether lipids, especially plasmalogens in neurodegenerative diseases. The aged mice were applied using this approach to investigate the change of fatty acid compositions during the aging process. We did observe certain acyl chain in PG, PI, and TG had changed percentage contributions in 2-year-old mouse brains. In PE lipids, only ether chain showed the difference during aging. Overall, the systematic analysis of the lipid molecule distribution in all major organs/tissues of Wistar rats, NMRI mice, and CD1 mice provides a coherent basis for the prediction of drug partition coefficient using mechanistic tissue composition-based equations commonly used in PBPK modeling [50].



---

*Source: 8819437-2020-11-30.xml*